Paper
KITE-753: A phase 2 study of an autologous anti-CD19/CD20 CAR T-cell therapy in CAR-naive patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL).
Journal of Clinical Oncology · 2026 · Saurabh Dahiya, Timothy J. Voorhees, Matthew L. Ulrickson et al.